Mgr. Karla Plevová, Ph.D.
Head of the research group, Karla Plevová Research Group: Genomics of Immune Cells
correspondence Address:
Jihlavská 340/20, 625 00 Brno
office: bldg. E35/258
Kamenice 753/5
625 00 Brno
phone: | +420 532 23 4396 |
---|---|
e‑mail: | |
web: | https://genomika.med.muni.cz/research/research-groups/karla-plevova-group/about-us |
social and academic networks: |
---|
Total number of publications: 359
2020
-
Real-world data on efficacy and safety of obinutuzumab plus chlorambucil, rituximab plus chlorambucil, and rituximab plus bendamustine in the frontline treatment of chronic lymphocytic leukemia: TheGO-CLLEARStudy by the CzechCLLStudy Group
Hematological Oncology, year: 2020, volume: 38, edition: 4, DOI
-
The impact of transposable elements in hematological malignances.
Year: 2020, type: Conference abstract
2019
-
Applications of the ARResT/Interrogate bioinformatic platform within ESLHO networks
Year: 2019, type: Conference abstract
-
Assessing suitability of various DNA sources for monitoring leukemia aktivity with WGS.
Year: 2019, type: Conference abstract
-
Bioinformatic pipelines for whole transcriptome sequencing data exploitation in leukemia patients with complex structural variants
PeerJ, year: 2019, volume: 7, edition: JUN, DOI
-
Biologická a klinická analýza souboru nemocných s refrakterní a relabující chronickou lymfocytární leukémií
Year: 2019, type: Conference abstract
-
Cílená inhibice kasein kinázy 1 v léčbě chronické lymfoidní leukémie.
Year: 2019, type: Conference abstract
-
Clinical impact of genomic analysis in children with B-acute lymphoblastic leukemia: A pilot study in Slovakia
Neoplasma, year: 2019, volume: 66, edition: 6, DOI
-
CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
Leukemia, year: 2019, volume: 33, edition: 2, DOI
-
Complex structural variants and de novo fusion gene expression in chronic lymphocytic leukemia
Year: 2019, type: Conference abstract